FDA Class III recall: buprenorphine 2 mg sublingual tablets, label mix-up

The FDA has listed an ongoing Class III recall of buprenorphine sublingual tablets 2 mg, in 30-tablet cartons, distributed by American Health Packaging. The stated reason is a labelling defect — a label mix-up. The recall is at the packager level and does not extend to buprenorphine as a molecule or to other manufacturers' stock.

Class III is the FDA's lowest recall class: the agency's own definition is a violation unlikely to cause adverse health consequences. That framing fits most labelling defects. It fits less comfortably on a controlled substance where the number printed on the carton is the entire dosing instruction, and where the patient population includes people in opioid substitution treatment for whom a wrong strength is not a trivial error.

Practically, this is a stock-check rather than a prescribing change. If you work in a service that dispenses buprenorphine from US-packaged supply, the action is to identify affected lots and verify the label against the tablet. Elsewhere it is a reminder that a strength read off the carton and never confirmed against the product is a single point of failure in a drug where strength matters.

• Check whether your service holds stock from the named packager and identify affected lots.
• Verify carton strength against tablet markings before dispensing rather than after.
• Do not change a stable patient's buprenorphine prescription on the basis of this recall.
• If a patient reports that recent tablets looked or felt different, take it seriously and check the pack.

Why it matters

On a controlled substance, the strength printed on the carton is the whole instruction — and here it may not match the contents.

Don't overread it

A Class III labelling recall is an administrative defect in one packager's stock, not a safety finding about buprenorphine.

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.